Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. de Laurentiis, D. Paris, D. Melck, A. Bianco, M. Sofia, A. Motta (Somma Vesuviana, Naples, Naples, Pozzuoli, Naples, Campobasso, Italy). EBC using metabonomic analysis to assess in holistic way smoking related airway diseases. Eur Respir J 2010; 36: Suppl. 54, 1270

Member's Comments

No comment yet.

Related content which might interest you: Multi-omics analysis of the healthy smoker airway reveals smoking related impacts on the lung microenvironment Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Do exhaled non-invasive inflammatory markers correlate with respiratory symptoms and lung function in a longitudinal study of childhood asthma? Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022 Is it possible to predict asthma outcomes? A disease model for economic analysis. Source: International Congress 2017 – Asthma management Year: 2017 Clinically-relevant computational model of airway remodelling to design and optimise interventions to treat asthma Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Overview and history of different ways of assessing and monitoring inflammatory airway diseases Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Leveraging causal modeling to predict future COPD Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype Source: Virtual Congress 2021 – Environment and air pollution Year: 2021 Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The use of toxicogenomics to identify biomarkers of exposure in an airway epithelium model exposed to tobacco smoke components Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006 Combining digital technologies to monitor asthma control and predict asthma exacerbations Source: Virtual Congress 2020 – Digital health: a brave new world? Year: 2020 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis Source: Eur Respir J, 51 (5) 1702173; 10.1183/13993003.02173-2017 Year: 2018 Validation process of a questionnaire assessing knowledge level concerning occupational asthma in asthmatic patients Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 Repeatability and inter-relationships of small airway biomarkers in asthma Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011